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2002; Berke, 2003). The hippocampus shows various functional 
states under the control of neuromodulators (Hirase et al., 2001). 
The role of DA has been less extensively studied because of the early 
view that the hippocampus did not receive a signiﬁ  cant dopaminer-
gic innervation (Loy et al., 1980). It is now recognized that the hip-
pocampus does receive such innervation (Gasbarri et al., 1994a,b). 
Anatomical and chemical observations indicate that hippocampal 
areas CA3, CA1 and subiculum receive DA projections from the 
VTA 10 (Scatton et al., 1980; Swanson, 1982; Verney et al., 1985) 
and express high levels of D1- and D2-like receptors (Bischoff et al., 
1980; Martres et al., 1985; Bruinink and Bischoff, 1986) and there 
has been progress in understanding its function.
Taken together, current evidence suggests that the neural mecha-
nisms underlying learning and memory are also a central com-
ponent of the classic reward circuitry underlying drug addiction 
(Kelley, 2004; Hyman et al., 2006). Speciﬁ  cally, synaptic plasticity 
has provided clear evidence that DA via D1/D5 receptors affects 
long-term potentiation (LTP), a form of synaptic plasticity thought 
to encode long-term memory. At the cellular level, DA agonists can 
affect synaptic transmission in the hippocampus and modulate 
the perforant path input to the hippocampus (Otmakhova and 
Lisman, 1996, 1998, 1999). Thus, synaptic plasticity may function 
as a mechanism by which psychoactive drugs can initiate signal 
transduction cascades that sustain drug reward or craving (Nestler 
and Aghajanian, 1997; Nestler, 2002; Kelley, 2004). At the behavioral 
level, the local application of a D1/D5 receptor antagonist into the 
dorsal hippocampus impairs learning (acquisition) and memory 
(expression) of drug-seeking behaviors such as systemic cocaine 
and morphine CPP (Rezayof et al., 2003; Zarrindast et al., 2005; 
Zornoza et al., 2005a,b), which suggest that despite the clear phar-
macological differences between psychostimulants and opiates, the 
hippocampus may be playing a key role in drug reward circuitry.
A unifying mechanism that would explain how the hippoc-
ampus may be playing such role in the drug reward circuitry 
is via the activation of local D1/D5 receptors which are known 
INTRODUCTION
Although the hippocampus has not traditionally been considered 
part of the “reward” circuitry, previous studies demonstrate the 
direct involvement of the hippocampus in mediating behaviors 
associated with drug reward. Using a classic model of reward, it 
was reported that rats press a lever to electrically stimulate their 
own hippocampus (Ursin et al., 1966). Rats will also self administer 
intrahippocampal dynorphin (Stevens et al., 1991) and dopamine 
(Stevens, 1989; pp: 83–102). Moreover, electrical self-stimulation was 
demonstrated in the granule cell layer (Collier et al., 1982; Collier 
and Routtenberg, 1984), CA3 and CA1 regions (Stevens, 1989; pp: 
14–35) and entorhinal cortex (Collier et al., 1977, 1982; Collier and 
Routtenberg, 1984) of the hippocampal formation. In addition to 
glutamatergic input from the PFC, the NAc receives glutamater-
gic afferents from the subiculum of the hippocampal formation 
(Groenewegen et al., 1987) and brief trains of electrical stimulation 
in the subiculum can evoke a signiﬁ  cant increase in DA efﬂ  ux in the 
NAc which persists for 20–30 min (Blaha et al., 1997; Taepavarapruk 
et al., 2000). Interestingly,   subicular electrical stimulation has also 
been shown to reinstate drug-seeking behavior (Vorel et al., 2001; 
Taepavarapruk and Phillips, 2003) whereas hippocampal-subicular 
pharmacological inactivation reduces drug-seeking and drug-taking 
behavior in rodents (Sun and Rebec, 2003; Black et al., 2004). Besides, 
using another classic model of reward, it was shown that morphine 
infusions into hippocampus induces a conditioned place preference 
(CPP) in rats (Corrigall and Linseman, 1988). Similarly, pharmaco-
logical hippocampal inactivation disrupts the acquisition of systemic 
cocaine-mediated CPP (Meyers et al., 2003, 2006). Moreover, asso-
ciating context-spatial locations with drug rewards is fundamental 
to survival in natural environments and requires the integrity of the 
hippocampus and ventral striatum (Lansink et al., 2009).
In addition, long-term neural adaptations resulting from repeated 
drug exposure involve an associative learning process (Wolf, 2002) 
that may require the hippocampus (Berke and Hyman, 2000; Berke 
and Eichenbaum, 2001; Nestler, 2001, 2002; Robbins and Everitt, 
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to enhance hippocampal LTP in vivo (Li et al., 2003). Enhanced 
 hippocampal LTP translates to an elevated CA1 output to medium 
spiny neurons in the NAc. Medium spiny neurons display a bist-
able subthreshold membrane property (O’Donnell and Grace, 
1995) and the up-state can be induced by enhanced activation 
of the hippocampal afferent ﬁ  bers (O’Donnell and Grace, 1998). 
The NAc medium spiny cell’s up-state in turn removes ventral 
pallidum (VP) tonic inhibition onto VTA DA neurons (Lisman 
and Otmakhova, 2001; Lisman and Grace, 2005), resulting in 
disinhibition of VTA DA cells. The activity of these cells is thought 
to be a key event in the early stages of drug addiction. A recent 
study showed that the activation of hippocampal afferents to the 
NAc modulate DA neuron responsivity by regulating the intensity 
of phasic neuron activation (Lodge and Grace, 2006).
The objective of this study was to investigate the role of the hip-
pocampus in mediating drug reinforcement. Speciﬁ  cally, we exam-
ined whether the intrahippocampal dialysis of methamphetamine 
(METH) into the dorsal hippocampus produces drug-seeking (CPP) 
and drug-taking (self administration) behavior in rodents. Further, 
we examined the role of local D1/D5 receptors in METH-induced 
intrahippocampal drug-seeking and drug-taking behavior.
MATERIALS AND METHODS
ANIMALS
The animals used in this study were 275–325 g male Sprague-Dawley 
rats (Harlan, Raleigh, NC, USA). The animals were housed individu-
ally in standard plastic laboratory cages (20 cm × 20 cm × 32 cm), 
on a 12:12 hour light:dark cycle (lights on at 07:00 hours) with access 
to food and water ad libitum. After arrival, the animals were allowed 
5 days to acclimate before any experimental procedures began. All 
animals were handled daily for 15 min during these 5 days. The 
animal use protocols were approved by the Institutional Animal Care 
and Use Committee at the University of Texas at San Antonio.
SURGERY
The animals were anesthetized with intraperitoneal (IP) injections 
of Nembutal (50 mg/kg; Abbott Laboratories, North Chicago, 
IL, USA). The animals were mounted in a stereotaxic appara-
tus and their skulls were exposed. A plastic guide cannulae with 
a stainless steel dummy cannulae (CMA/Microdialysis, Acton, 
MA, USA) was directed at either the right dorsal hippocampus 
(coordinates: AP −3.5 mm from bregma, ML 2.5 mm from the 
midsagittal suture, DV −2.8 mm from the skull surface) or lat-
eral cortex (CTX) (coordinates: AP −3.5 mm from bregma, ML 
5.5 mm from the midsagittal suture, DV −2.8 mm from skull sur-
face). All coordinates were based on (Paxinos and Watson, 2007). 
The hippocampal coordinates used in this study are consistent 
to regions rich in DA receptor expression and function (Bischoff 
et al., 1980; Scatton et al., 1980; Bruinink and Bischoff, 1986). 
Following implantation, the guide cannulae was anchored to the 
skull using three skull screws and dental cement. Animals received 
an intramuscular injection (0.3 ml) of penicillin (22,500 U/ml) 
into each thigh after the surgery to prevent infection and were 
given water treated with acetaminophen (0.32 mg/ml) for 3 days 
to reduce post surgery discomfort. Animals were allowed 3–7 
days to recover from surgery before experimental procedures 
were initiated.
ANATOMICAL CONTROL
A separate group of animals with probe placements in the lateral 
distal cortex was added as an anatomical control. These animals 
were trained for CPP and self administration procedures just as 
the other groups. Anatomical control regions used in this study 
included the overlying cortex directly above the hippocampus 
(CTXa) and the somatosensory cortex lateral to the hippocampal 
coordinates used in this study (CTXb).
DRUGS
The Ringer’s vehicle solution (Baxter, Deerﬁ  eld, IL, USA) was com-
posed of: 6 mg/ml NaCl, 3.1 mg/ml sodium lactate, 0.3 mg/ml KCl, 
and 0.2 mg/ml CaCl2. Dextro-methamphetamine hydrochloride 
(METH, Sigma Chemical Co., St. Louis, MO, USA) was dissolved 
in Ringer’s solution at a concentration of 10 µg/µl and was prepared 
daily. The dopamine D1/D5 receptor selective antagonist SCH 23390 
(100 and 250 µM/µl) was dissolved in Ringer’s solution and was 
prepared daily (Sigma Chemical Co., St. Louis, MO, USA). Radio-
labeled [3H] dextro-  methamphetamine (1.5 mM) was obtained 
from the National Institute on Drug Abuse, Baltimore, MD, USA.
APPARATUS
CPP was examined using Plexiglas chambers (70  cm 
W × 22 cm D × 33 cm H) which consisted of two end chambers 
(26 cm W × 22 cm D × 33 cm H) and one smaller center chamber 
(18 cm W × 22 cm D × 33 cm H) (San Diego Instruments, San 
Diego, CA, USA). Each of the three chambers had four photo 
beams and sensors. The CPP apparatus was controlled by soft-
ware (provided by San Diego Instruments) and was connected to 
a computer which ran the software Photobeam Activity System 
(PAS). The CPP apparatus was experimentally manipulated to cre-
ate a bias toward the left black compartment in contrast to a right 
white compartment. The CPP apparatus also included a neutral 
gray center smaller compartment. Previous work from our labora-
tory has shown that rats express a bias for a particular side, with 
most preferring the dark black compartment. Self administra-
tion was examined using computer-controlled operant chambers 
housed inside sound attenuating boxes (Coulbourn Instruments, 
Allentown, PA, USA). Inside the sound attenuating chamber, a 
Skinner chamber housed the hardware-apparatus. One wall of 
each chamber contained two levers, a cue light above one lever, 
and a house light. One lever was designated as the active lever 
and when pressed activated a pump via a swivel. Activation of 
the pump initiated dialysis for 60 s. The other level was inactive 
and responding on this lever had no programmed consequence. 
Inactive lever presses were used as an index of overall locomotor 
activity. The houselight illuminated the inside of the chamber 
throughout the behavioral procedure.
CONDITIONED PLACE PREFERENCE PARADIGM
The CPP paradigm consisted of three phases: preconditioning, 
conditioning and post-conditioning. For the pre and post con-
ditioning phases, animals were placed in the neutral gray center 
compartment and the sliding doors were removed to allow equal 
access to the entire apparatus for 15 min. The amount of time 
each rat spent in each compartment was monitored to deter-
mine the initial   preference. During the conditioning phase, the Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  3
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 animals received either a Ringer’s vehicle or METH (drug delivery 
described below) solution dialysis for the ﬁ  rst 10 of the 30 min ses-
sions for eight conditioning sessions in a counterbalanced design. 
Speciﬁ  cally, each animal received four METH dialyses in their 
initially non-preferred side (drug-paired side) and four vehicle 
(Ringer’s) dialyses in their initially preferred side (vehicle-paired 
side). Animals were conﬁ  ned to the appropriate compartment 
for the entire conditioning session (30 min) blocking access to 
the neutral compartment by the sliding door. The data reported 
herein showed that rats initially expressed a bias for a particular 
side, with most preferring the dark black compartment. For the 
post-conditioning tests, the animals were allowed to access the 
entire apparatus in a drug free-state or in the presence of local 
SCH 23390. The drug doses and dialysis procedures are described 
below. The CPP apparatus had a biased design (i.e., drug was 
administered on the initially non-preferred side) and thus the 
relative amount of time spent in each compartment before vs. after 
conditioning was used to assess the CPP. The CPP data reported 
here is shown as the “time difference” and such was calculated by 
subtracting the time spent in the initially non-preferred side of 
the apparatus (drug-paired) and the time spent in the same side 
during the post-conditioning test. Therefore, a positive value is 
indicative of “reward” and a negative value is sometimes inter-
preted as “aversion” (Bardo et al., 1996; Bardo, 1998). It is impor-
tant to mention that overall METH treated rats spent signiﬁ  cantly 
more time in the initially non-preferred compartment than the 
initially preferred compartment following drug conditioning sug-
gesting a true reward measurement and ruling out an anxiety 
reduction effect (data not shown). For a full discussion on this 
topic see (Tzschentke, 1998).
SELF ADMINISTRATION PARADIGM
All animals trained in CPP were trained to lever press for intrahip-
pocampal dialyses of METH. Operant conditioning consisted of 
daily 30 min sessions for 8 days. At the beginning of each session 
following a 45-s delay, the ﬁ  rst trial of the session began by having 
a cue-light turned on above the active lever which remained on for 
60 s signaling drug availability. During this drug available period, 
a single active lever press activated the pump. The activation of 
the pump initiated a 60-s dialysis period. After the pump turned 
off, it remained off for another 60 s (inter-trial interval) and then 
another trial began. If the “active” lever was not pressed during the 
60 s drug availability period, the cue-light turned off and remained 
off for another 60 s and then again turned on for another trial. 
During the cue-light illuminated drug availability period (duration 
of the session from 0 to 59 s), a single active lever-press resulted in 
delivery of either 2 µl of Ringer’s or METH solution through the 
probe into the hippocampus. The active lever presses that activated 
the pump were deﬁ  ned as “lever presses yielding dialysis” for the 
data presentation. Pressing of the active lever after the pump was 
activated had no consequence but was measured to display condi-
tioned behavior and these responses were deﬁ  ned as “lever presses 
during dialysis”. The last three sessions of self administration, the 
antagonist SCH 23390 was co-administered with METH to either 
the hippocampus or the CTX (depending on group). During the 
conditioning session an   inactive lever was present and was always 
extended. A bar press on the inactive lever had no programmed 
consequence and was called “inactive lever presses.” The inactive 
lever presses were measured to monitor of baseline lever presses in 
the absence of reinforcement (i.e., general motor activity).
DRUG DELIVERY VIA REVERSE MICRODIALYSIS
All rats were taken from the colony room and brought to the experi-
mental room 60–90 min prior to each daily session (CPP or self 
administration). The microdialysis probes were pre-loaded by con-
necting them to the infusion pumps and continuously dialyzed with 
either Ringer’s vehicle or METH solution (10 µg/µl) at a ﬂ  ow rate 
2.0 µl/min. The pre-loading process was evident because solution 
appeared on the outﬂ  ow side of the probe, which took approximately 
10 min. For all experiments, a new pre-loaded microdialysis probe 
was inserted through the guided cannulae prior to every session. The 
tip of the microdialysis membrane is closed and thus only the lateral 
sides of the microdialysis probe are in contact with surrounding 
tissue and are accessible to dialysis. This is important to mention 
as probe placements are within dorsal hippocampal regions where 
DA receptors are expressed. For experiments where SCH 23390 was 
used, the antagonist SCH 23390 (100 and 250 µM/µl) was dissolved 
in either Ringer’s solution or METH.
HISTOLOGY
Cannulae placement was determined from coronal, thionin-stained 
50 µm sections. After completion of behavioral testing, each animal 
was euthanized with an overdose of Nembutal (100 mg/kg, IP).
ANATOMICAL SPECIFICITY
The following experiment was designed to examine if METH diffu-
sion within the hippocampus is spatially limited. The Hippocampus 
of those animals that received [3H] d-methamphetamine was 
further dissected into three regions (1, 2 and 3) for the [3H] 
d-  methamphetamine diffusion experiment explained below. The 
dissection consisted in separating the right hemisphere and remov-
ing the overlying cortex. The overlying cortex (CTXa) and the lateral 
cortex (CTXb) to the hippocampus were distal regions and used in 
this experiment as an anatomical control. All dissected brain regions 
were examined using a scintillation counter to measure disintegra-
tions per minute and thus calculate counts per minute (cpm) per 
microliter of tissue to determine local brain drug concentration fol-
lowing [3H] METH dialysis. To determine how much radio-labeled 
METH would dialyze through the microdialysis probe we would be 
using, we ﬁ  rst prepared a 10-µg/µl stock METH solution in 1.0 ml 
Ringer’s vehicle by adding 5.4 µl out of the stock [3H] radioactive-
labeled METH (1.5 mM). This METH mixture was the solution 
that went in the syringe and deﬁ  ned as the dialysate. Two additional 
control 5.0 µl aliquots were made from the stock METH mixture 
solution and these were placed in scintillation vials. To one of these 
control background vials, a comparable hippocampus brain sample 
was added as a tissue quenching effect. To these two additional 
samples we added a known amount of radioactive-labeled METH 
and these were used as controls to relate radiation quantiﬁ  cation 
to local brain concentration. The METH mixture dialysate con-
tained 180,391 cpm/µl. This is the dialysate that was dialyzed in vivo 
for either 10 or 30 min (data not shown). Although all dialyses in 
behavioral testing did not exceed 10 min, we purposely tripled the 
duration (30 min) to show that even at long dialysis durations, Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  4
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spatial diffusion is discrete. Animals were decapitated 30 min after 
completing the 10 or 30 min dialysis period and their brains rapidly 
removed for dissection (as described above) and the tissue was 
placed in glass vials. Each vial contained either a known amount 
of METH solution as background or the tissue of interest. To each 
vial, we added 10 ml of scintillation ﬂ  uid (Aquasol) and using a 
Pasteur pipette the tissue was broken up and homogenized before 
placing the vials in the scintillation counter (Beckman LS2800, 
Beckman Instruments Inc., Fullerton, CA, USA).
STATISTICAL ANALYSIS
Only animals with correct probe placements were included in the 
analysis. Approximately, 80% of all animals had accurate probe 
placements. Statistical analyses (one-way and two-way ANOVAs) 
were used to determine statistical signiﬁ  cance of the treatment 
(METH or Ringer’s) as the between factor, and days of training or 
“time spent” (pre and post-conditioning in drug-paired side) as 
the within factor. The Tukey test was used to determine signiﬁ  cance 
during preplanned post hoc pair-wise comparison analysis.
RESULTS
HISTOLOGY
Figure 1 inset illustrates a coronal section of the brain of a rep-
resentative rat that received multiple dialysis probe insertions 
(17) after completing both CPP and self administration experi-
ments. Animals included in the anatomical control groups had 
stereotaxic coordinates directed towards the secondary somatic 
sensory cortex/barrel cortex and were included only if they 
had accurate   placements. Approximately 20% of all completed 
 surgical  placements to animals were excluded based on inaccurate 
13 2
CTXa
CTXb
A B
FIGURE 1 | Intrahippocampal METH-induced CPP is spatially discrete and 
modulated via local D1/D5 receptors. (A) The effects of intrahippocampal 
METH 10 µg/µl (n = 12) or Ringer’s (n = 10) on CPP Test 1 (white bars) and the 
effects of local SCH 23390 application (black bars) prior to Test 2 (to examine 
CPP Expression) of either Intrahippocampal METH trained rats for CPP (n = 7) or 
vehicle (n = 6). (B) The effects of intrahippocampal METH 10 µg/µl (n = 6) or 
Ringer’s (n = 5) on CPP Test 1 (white bars) and the effects of local SCH 23390 
co-application with METH (black bars) during conditioning (to examine CPP 
Acquisition) of either Intrahippocampal METH CPP (n = 6) or Ringer’s (n = 6). 
The inset at the bottom left shows a coronal section of the brain of a 
representative rat that received multiple dialyses. Hippocampal sub regions (a, b 
and c) and cortical areas (CTXa) and (CTXb) used for the scintillation counter 
experiment are labeled. The inset at the bottom right shows scintillation counter 
measurements (CPM) of [3H] METH revealing limited diffusion within 
hippocampus during a 10-min dialysis where the microdialysis probe was 
located (1, 2, 3). Overlying tissue (CTXa) and lateral regions (CTXb) did not reﬂ  ect 
any CPM revealing limited diffusion. The symbol * represents a statistical 
difference from all the other groups (P < 0.05).Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  5
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CONDITIONED PLACE PREFERENCE EXPERIMENTS
The objective of this experiment is to determine if METH 
 administration into the dorsal hippocampus is rewarding as meas-
ured by CPP. Here we show (Figures 1A,B), that animals receiving 
METH reveal a positive CPP score (Test 1: METH group white 
bars) as compared to the Ringer’s vehicle treated animals. Further, 
the METH-induced preference is completely blocked if the D1/D5 
antagonist (SCH 23390) is administered prior to the CPP post-
conditioning Test 2, (METH black bar; Figure 1A) to examine CPP 
expression. We also demonstrate that if the administration of the 
local antagonist occurs during conditioning to examine CPP acqui-
sition, the METH-induced CPP effect is reduced (METH black 
bar; Figure 1B). We then asked if the D1/D5 antagonist would 
also block the already reduced METH-induced CPP expression 
observed when the antagonist was co-administered with METH 
during conditioning (Figure 2A; white bars). Our results reveal that 
the local application of SCH 23390 prior to Test 2 (black bars) failed 
to block the reduced METH-induced effect in animals with prior 
exposure to the antagonist (Figure 2A; black bar). Not surpris-
ingly, just as before, the application of SCH 23390 prior to Test 2 
(black bars) completely blocked the positive METH-induced CPP 
in METH treated animals without prior exposure to the antagonist 
(Figure 2A; black bar).
Furthermore, the METH-induced effect is speciﬁ  c to the hip-
pocampus as the dialysis of METH into the lateral Cortex (CTXb; 
see Figure 1 inset) failed to elicit a positive CPP (Figure 2B; white 
bars). Additionally, we report that a lower dose (100 µM) of the 
antagonist signiﬁ  cantly blocks METH-induced CPP expression 
(retrieval) in animals with microdialysis probes in their hippoc-
ampus (Figure 2B; black bars).
LOCOMOTOR ACTIVITY (SHUFFLING BEHAVIOR)
This purpose of this experiment is to show that that the usage of 
the selective D1/D5 antagonist (SCH 23390) used in this study to 
signiﬁ  cantly block the METH-induced CPP does not signiﬁ  cantly 
affect locomotor activity as we measured shufﬂ  ing behavior (the 
number of crosses across the three compartments on precondition-
ing (white bar) and post conditioning Test 1 (gray bar) and Test 2 
(black bar; Figure 2C).
SELF ADMINISTRATION EXPERIMENTS
Earlier, we demonstrated that the application of METH directly 
into the hippocampus is rewarding as measured by CPP. In this 
experiment, we supplement the initial CPP ﬁ  ndings by revealing 
that intrahippocampal METH also sustains lever pressing behavior 
(Figures 3A,B). Interestingly, the lever pressing behavior during 
the dialysis period (see Section “Materials and Methods”) is far 
greater than the active presses yielding dialysis upon pump acti-
vation (data included in overall average lever presses shown in 
Figure 4) suggesting a local METH-induced positive reinforce-
ment behavior. The local application of the D1/D5 antagonist SCH 
23390 (100 and 250 µM) during the last 3 days impaired over-
all active lever pressing behavior in the METH treated animals 
(Figures 4A,B). Further, it is shown METH-induced lever pressing 
behavior is speciﬁ  c to the hippocampus (Figures 3A and 4A) and 
not the cortex (Figures 3B and 4B).
 cannulae placement and dialysis failures that occurred during the 
 experiments.  Figure 1 inset also illustrates the hippocampal and 
cortical regions dissected for the radio-labeled METH diffusion 
experiment.
ANATOMICAL SPECIFICITY
This experiment reveals that the intrahippocampal dialysis of 
METH into the dorsal hippocampus is spatially discrete as diffusion 
within the hippocampus is limited (Figure 1 inset). The hippoc-
ampus was dissected into three regions (1, 2 and 3). The overlying 
cortex (CTXa) and the cortex (CTXb) lateral to the   hippocampus 
were distal regions used as anatomical controls. All dissected brain 
regions were examined using a scintillation counter to measure 
disintegrations per minute and thus calculate counts per minute 
per microliter of tissue to determine local brain drug concentration. 
Theoretically, in 10 min (duration of typical drug dialysis in CPP 
experiments) at a 2-µl/min ﬂ  ow rate, 20 µl are dialyzed. Using a 
scintillation counter we measured that 180,391 cpm of HOT METH 
were present in 1 µl of dialysate and such counts considered 100% 
of available METH dialysis counts per microliter (see Figure 1 
bottom right inset “No Tissue” Column). Following a 10 min int-
rahippocampal dialysis with the METH dialysate, we found that 
183,852 cpm were measured (see Figure 1 inset,   adding columns 
3, 4, 5). We can calculate that up to 20 µl are dialyzed, yielding an 
estimated 9192 cpm/µl during dialysis which is roughly 5% of the 
total counts found in 1 µl of the original METH dialysate men-
tioned above. Such theoretical in vivo approximation is comparable 
to the 10% microdialysis recovery estimates from in vitro studies 
(Rodriguez et al., 2008) if considering that the active membrane 
length used in that study was 1.5 mm compared to 1.0 mm in this 
study. Furthermore, if assuming a similar radial diffusion of 0.5 
to a 1-mm from the wall of the microdialysis probe’s membrane 
as estimated in other microdialysis studies (Wozniak et al., 1991; 
Gonzales et al., 1998), then the total volume of tissue affected would 
be approximately 1 µl of tissue (excluding probe displacement vol-
ume). Based on volumetric studies, the unilateral dorsal hippocam-
pal volume would be equivalent to 50 µl where the probe placement 
was positioned (Kalisch et al., 2006). Further if we concentrate on 
the precise location of the probe location, we can then calculate 
that during a 10-min dialysis session, a total of 110,369 cpm (see 
Figure 1 inset, Column 3) divided by the approximated hippoc-
ampal volume (∼50 µl) yields total METH counts per microliter 
of tissue or 2207.38 METH cpm/µl of tissue. Thus, the mean total 
counts of METH per microliter of tissue are 2207.38 cpm/µl. In 
other words, the mean total counts after a 10-min intrahippoc-
ampal dialysis are 1.2% of that found in 1 µl of the dialysate, and 
this was deﬁ  ned as the diffusion factor. Therefore the mean con-
centration of METH in the hippocampal tissue following a 10-min 
dialysis with 53.3 mM (10 µg/µl) would be 0.625 mM or 625 µM 
by multiplying by the diffusion factor above. This is equivalent to 
a total of 5.8 µg of METH after a 10-min dialysis or ∼ 34 nmol 
in 50 µl of tissue. The diffusion factor calculated here to estimate 
local brain drug concentration is a similar attempt as to previous 
experimental approaches with reverse microdialysis as a method of 
brain drug delivery (Wise et al., 1995; Robinson et al., 2000; Vezina 
et al., 2002; Crespo et al., 2006).Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  6
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DISCUSSION
DRUG DELIVERY VIA REVERSE MICRODIALYSIS ADVANTAGES
In this study, a microdialysis probe was used to deliver the 
  reinforcer by reverse dialysis to reduce the high pressure com-
monly caused by multiple infusions with open-ended cannulaes. 
The effects involved with multiple infusions into discrete brain 
regions could be attributed to a physical–chemical interaction on 
neuronal ﬁ  bers, not necessarily due to direct synaptic action. To 
respond to this potential problem; the use of reverse microdialysis 
offers the advantage of maintaining the drug concentration along 
the membrane due to its slow ﬂ  ow rate with the volume being 
dialyzed over a long period of time and without spread beyond 
the site of interest (Quan and Blatteis, 1989). Thus, the reverse 
microdialysis technique offers reliable drug diffusion over the 
desired area without pressure injection variability since there is 
no volume transfer into the brain evoking a true synaptic action 
rather than a physical–chemical interaction (Bazzett et al., 1991). 
Not surprisingly, the reverse microdialysis drug delivery method 
has provided a powerful technique for the study of local drug 
action and been used extensively in the brain and other tissues and 
has been thoroughly reviewed in the literature (Hocht et al., 2004, 
2007; Plock and Kloft, 2005). The drug concentrations used in this 
FIGURE 2 | Role of local D1/D5 receptors in the acquisition and expression 
of intrahippocampal METH CPP . (A) The effects of intrahippocampal METH 
µg/µl (n = 6) or Ringer’s (n = 5) on CPP Test 1 and the effects of local SCH 
23390 on CPP acquisition (Test 1) and CPP expression (Test 2) of 
intrahippocampal METH CPP (n = 6) or Ringer’s vehicle (n = 6). (B) METH only 
induces CPP in the hippocampus and not the cortex (CTX). The effects of 
intracranial METH (hippocampus n = 13 or CTX n = 10) or Ringer’s 
(hippocampus n = 11 or CTX n = 10) on CPP and local SCH 23390 on CPP 
acquisition (Test 1) and expression (Test 2) of intrahippocampal METH CPP . The 
symbol * represents a difference from all other groups (P < 0.05). (C) Local 
hippocampal D1/D5 antagonism does not affect locomotor activity. White bar 
represents crosses during pre conditioning test. The gray bar is activity during 
the ﬁ  rst drug-free test while the black bar is activity in the presence of the D1/D5 
antagonist (100 µM).Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  7
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FIGURE 3 | Intrahippocampal METH sustains self administration. 
(A) Cumulative lever presses per day on the active and inactive levers during the 
30-min test sessions across 7 days. Rats in the Ringer’s (n = 11) and METH 10 µg/µl 
(n = 12) groups were co-treated with 250 µM SCH during days 5–7 . METH 10 µg/µl 
group active lever presses were signiﬁ  cantly greater than Ringer’s group active 
lever presses from day 3 onward. METH group: upside-down black triangles; 
METH inactive: light gray diamonds; Ringer’s: dark gray triangles. (B) METH 
induces lever-pressing in the hippocampus and not the cortex (CTX). All groups 
were co-treated with 100 µM SCH 23390 during days 5–7 . Intrahippocampal METH 
group active lever presses were signiﬁ  cantly greater than CTX METH and Ringer’s 
vehicle groups from day 2 onward. The symbol * represents a difference from all 
other groups (P < 0.05). Hippocampus METH group: upside-down black triangles; 
Hippocampus METH inactive: light gray diamonds; Hippocampus Ringer’s: dark 
gray triangles; CTX METH: black ﬁ  lled circles.
FIGURE 4 | Intrahippocampal METH self administration is modulated via 
local D1/D5 receptors. (A) Average lever presses on the active and inactive 
levers during the 30-min test sessions across 7 days. Rats in the Ringer’s 
(n = 12) and METH 10 µg/µl (n = 17) groups were co-treated with 250 µM SCH 
23390 during days 5–7 (black bars). METH group active lever presses were 
signiﬁ  cantly greater than Ringer’s group active lever presses. Local application of 
SCH 23390 impairs (black bars) impairs METH lever pressing behavior. 
(B) METH only induces lever-pressing in the hippocampus and not the cortex 
(CTX). All groups were co-treated with 100 µM SCH 23390 during days 5–7 . 
Intrahippocampal METH group active lever presses were signiﬁ  cantly greater 
than CTX METH and Ringer’s vehicle groups from day 2 onward. The symbol * 
represents a difference from all other groups (P < 0.05).
study are 10-fold higher than those generally found in brain slice 
superfusion experiments, and were chosen to compensate for the 
spatial and temporal limitations associated with drug administra-
tion by reverse microdialysis, usually done in other studies (Hoebel 
et al., 1983; Johnson and Justice, 1983; Kurata and Shibata, 1991; 
Zornoza et al., 2005b; Rodriguez et al., 2008).
GENERAL DISCUSSION
The hippocampus is a particularly suitable structure in which 
to study the role of psychostimulants in light of its exceptional 
monoaminergic innervation and its support of ICSS (Ursin 
et al., 1966; German and Bowden, 1974). Very few studies have 
investigated the neurochemical substrates of intrahippocampal Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 47  |  8
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with augmented DA release in the hippocampus (Ihalainen et al., 
1999), which facilitates hippocampal CA1 LTP induction. Not sur-
prisingly, hippocampal application of DA agonists in naïve rats also 
facilitates LTP induction and enhances learning (Li et al., 2003). 
Dopaminergic facilitation of learning has been well demonstrated 
by examining the role of DA receptors in memory facilitation on 
various learning tasks (Packard and White, 1989, 1991).
It is known that the hippocampus projects to the NAc onto 
medium spiny neurons. Medium spiny neurons display a bistable 
subthreshold membrane property (O’Donnell and Grace, 1995). 
The up-state can be induced by activation of hippocampal affer-
ent ﬁ  bers onto NAc (O’Donnell and Grace, 1998). In our study, it 
is likely that the intrahippocampal METH dialysis increases local 
hippocampal extracellular DA concentration translating into an 
increased hippocampal afferent input to the NAc sufﬁ  cient to induce 
the NAc medium spiny cell’s up-state removing VP tonic inhibition 
onto VTA DA neurons (Lisman and Otmakhova, 2001; Lisman and 
Grace, 2005). VTA DA neuron activity states are modulated depend-
ing on their distinct afferent pathways (Floresco et al., 2003). Thus, 
overall DA neuron burst ﬁ  ring induce large transient elevations in 
synaptic DA release in NAc (Chergui et al., 1994) and hippocam-
pus (Ihalainen et al., 1999) and considered to be the postsynaptic 
signals encoding reward prediction (Schultz, 1998), indicate incen-
tive salience (Berridge and Robinson, 1998); and novelty detection 
(Ihalainen et al., 1999). In fact, a recent study showed that the hip-
pocampus indeed modulates DA neuron responsivity by regulating 
the intensity of phasic neuron activation (Lodge and Grace, 2006). 
Local transient increases in hippocampal DA levels are known to 
trigger downstream second messenger systems resulting in gene 
expression and protein synthesis enabling long-lasting changes in 
synaptic plasticity such as enhanced LTP in the hippocampus CA1 
region following cocaine self administration (Thompson et al., 2002, 
2004, 2005; del Olmo et al., 2006a,b; Swant and Wagner, 2006).
Taken together, the results suggest a role for the hippocampus in 
drug-seeking (CPP) and drug-taking behavior (self administration). 
Further, we found that both of these behaviors are modulated in 
part by local hippocampal D1/D5 receptors. These results implicate 
the hippocampus as a signiﬁ  cant site for drug reward/reinforcement 
probably by making use of the anatomical circuit to the VTA via 
the NAc and VP (Lisman and Grace, 2005). Alternatively, the hip-
pocampus may be a functional link between learning and memory 
and reinforcement by demonstrating that reinforcement occurs in 
a structure intimately associated with learning and memory.
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electrical self-stimulation behavior (Ursin et  al., 1966). In one 
study, lesioning the locus coeruleus failed to disrupt intrahip-
pocampal electrical self-stimulation (van der Kooy et al., 1977). 
Interestingly, hippocampal lesions lowered intra-VTA electrical 
self-stimulation (Van Wolfswinkel and Van Ree, 1984). Another 
study showed that microinfusion of amphetamine into the NAc 
enhanced intra-subiculum electrical stimulation rates (Sweet and 
Neill, 1999). Remarkably, there are only few reports of intracra-
nial CPP (Corrigall and Linseman, 1988) and self administration 
of drugs directly into the hippocampus (Stevens et al., 1991). In 
this respect, the hippocampus remains largely unexplored in the 
context of local drug-induced reinforcement, despite consider-
able neuroanatomical and neurochemical observations indicating 
the presence of potential neurotransmitters that are known to be 
important in drug reinforcement.
Here, we show the ﬁ  rst demonstration that the hippocampus 
is a site for METH-induced (via reverse microdialysis) CPP and 
lever-pressing behavior. The data reported herein supports other 
hippocampal electrical stimulation ﬁ  ndings (Ursin et al., 1966), and 
in vitro slice physiological experiments (Corrigall and Linseman, 
1980, 1988; Linseman and Corrigall, 1981, 1982, 1984; Stevens 
et al., 1991) suggesting a role for the hippocampus in drug reward/
reinforcement. Furthermore, we show that the METH-induced 
drug-seeking and drug-taking behaviors are mediated at least in 
part via D1/D5 receptors. The evidence shows that intrahippocampal 
dialysis of SCH 23390 impairs local METH-induced CPP acquisition 
while completely blocking CPP expression and effectively impair-
ing lever pressing behavior. Interestingly, others have reported that 
local blockade of hippocampal D1/D5 receptors by pharmacologi-
cal inactivation with the same selective DA antagonist used here 
(SCH 23390) also impairs the acquisition and retrieval of systemic 
morphine-mediated (Rezayof et al., 2003, 2007; Zarrindast et al., 
2005) and ethanol-mediated (Rezayof et al., 2007) CPP. In addi-
tion, recent evidence suggests a role for the hippocampus in modu-
lating reward via the NAc (Van Wolfswinkel and Van Ree, 1984; 
Mittleman et al., 1998; Bardgett and Henry, 1999; Taepavarapruk 
et al., 2000; Gimenez-Llort et al., 2002; Taepavarapruk and Phillips, 
2003; Zornoza et al., 2005a,b). Speciﬁ  cally, some studies examined 
the role of hippocampal DA receptors. For example, one report 
revealed that the intrahippocampal application of the D1/D5 receptor 
antagonist SCH 23390 (100 and 250 µM) via reverse microdialysis 
caused a decrease in the local NAc extracellular DA concentration 
in rodents (Zornoza et al., 2005b).
Further, the hippocampus has also been proposed as a site 
for novelty detection that uses DA as a “signal” (Lisman and 
Otmakhova, 2001). Recordings from DA cells in monkeys have 
shown that DA cells respond rapidly with bursts of spikes to “novel” 
stimuli (Ljungberg et al., 1992) and as the stimuli become familiar, 
DA neurons no longer show this transient change in activity. The 
novelty-induced change in DA cell ﬁ  ring activity has been linked 
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